Total Compensation FY2025
$8.8M
As reported in 2026 DEF 14A proxy filing with the SEC
Compensation Breakdown
Base Salary
—
0% of total
Stock Awards
—
0% of total
Bonus
—
0% of total
Other Compensation
—
0% of total
Compensation History
Total compensation by fiscal year, as reported in SEC proxy filings.
About Robert Ford
Robert Ford has served as Abbott's CEO since 2020, leading the company's rapid COVID-19 testing development.
Data Source: Compensation figures are sourced from Abbott Laboratories's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2025 as reported in the Summary Compensation Table.